FRI-220 - Excellent cure rates in largest ESRD patient cohort who completed treatment with full dose, daily sofosbuvir-based regimens

Autor: Nazario, H.E., Modi, A.A., Ndungu, M., Ramirez, R., Tujague, L., Weinstein, J.S.
Zdroj: In Journal of Hepatology 2017 66(1) Supplement:S507-S507
Databáze: ScienceDirect